Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiam Chemaitelly

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Scientific Reports|March 19, 2021
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemicLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|January 28, 2022
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infectionsLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|August 9, 2022
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineageHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Scientific Reports|June 5, 2021
Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence populationGheyath K Nasrallah, Soha R Dargham, Farah Shurrab, et al.
Open Forum Infectious Diseases|March 17, 2025
Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Open Respiratory Research|March 26, 2025
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severitiesLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
Journal of Global Health|February 9, 2022
Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experienceRaghid Bsat, Hiam Chemaitelly, Peter Coyle, et al.
Plos Medicine|December 16, 2021
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort studyLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Journal of Travel Medicine|September 30, 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfectionHiam Chemaitelly, Nico Nagelkerke, Houssein H Ayoub, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Scientific Reports|March 19, 2021
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemicLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|January 28, 2022
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infectionsLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Nature Communications|August 9, 2022
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineageHiam Chemaitelly, Houssein H Ayoub, Peter Coyle, et al.
Scientific Reports|June 5, 2021
Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence populationGheyath K Nasrallah, Soha R Dargham, Farah Shurrab, et al.
Open Forum Infectious Diseases|March 17, 2025
Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in QatarLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
BMJ Open Respiratory Research|March 26, 2025
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severitiesLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
Journal of Global Health|February 9, 2022
Characterizing the effective reproduction number during the COVID-19 pandemic: Insights from Qatar's experienceRaghid Bsat, Hiam Chemaitelly, Peter Coyle, et al.
Plos Medicine|December 16, 2021
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort studyLaith J Abu-Raddad, Hiam Chemaitelly, Houssein H Ayoub, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Journal of Travel Medicine|September 30, 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfectionHiam Chemaitelly, Nico Nagelkerke, Houssein H Ayoub, et al.
Pageof 16